IL99077A0 - New embodiments of the hiv principal neutralizing determinant and pharmaceutical compositions containing them - Google Patents
New embodiments of the hiv principal neutralizing determinant and pharmaceutical compositions containing themInfo
- Publication number
- IL99077A0 IL99077A0 IL99077A IL9907791A IL99077A0 IL 99077 A0 IL99077 A0 IL 99077A0 IL 99077 A IL99077 A IL 99077A IL 9907791 A IL9907791 A IL 9907791A IL 99077 A0 IL99077 A0 IL 99077A0
- Authority
- IL
- Israel
- Prior art keywords
- pharmaceutical compositions
- compositions containing
- new embodiments
- neutralizing determinant
- principal neutralizing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/21—Retroviridae, e.g. equine infectious anemia virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6068—Other bacterial proteins, e.g. OMP
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Oncology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US56665690A | 1990-08-13 | 1990-08-13 | |
US56665490A | 1990-08-13 | 1990-08-13 | |
US56663890A | 1990-08-13 | 1990-08-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
IL99077A0 true IL99077A0 (en) | 1992-07-15 |
Family
ID=27415998
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL99077A IL99077A0 (en) | 1990-08-13 | 1991-08-05 | New embodiments of the hiv principal neutralizing determinant and pharmaceutical compositions containing them |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP0471407A3 (xx) |
JP (1) | JPH06321808A (xx) |
KR (1) | KR920004422A (xx) |
AU (1) | AU642751B2 (xx) |
CA (1) | CA2048594A1 (xx) |
FI (1) | FI913817A (xx) |
IE (1) | IE912846A1 (xx) |
IL (1) | IL99077A0 (xx) |
NO (1) | NO913127L (xx) |
NZ (1) | NZ239281A (xx) |
PT (1) | PT98633A (xx) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0519554A1 (en) * | 1991-06-19 | 1992-12-23 | Merck & Co. Inc. | Conjugates of the class II protein of the outer membrane of neisseria meningitidis and of HIV-1 related peptides |
US5556744A (en) * | 1992-05-29 | 1996-09-17 | The Trustees Of The University Of Pennsylvania | Methods and compositions for diagnosing and treating certain HIV infected patients |
GB2282380A (en) * | 1993-09-30 | 1995-04-05 | Merck & Co Inc | Conjugate of epitopes of HIV with a protein complex from Neisseria |
GB2282378A (en) * | 1993-09-30 | 1995-04-05 | Merck & Co Inc | Conjugates of epitopes of HIV with a protein complex from Neisseria |
DE59510092D1 (de) * | 1994-07-25 | 2002-04-11 | Roche Diagnostics Gmbh | Hapten-markierte peptide |
GB2294047A (en) * | 1994-10-14 | 1996-04-17 | Merck & Co Inc | Synthetic peptides for use as epitopes specific for HIV |
ES2293643T5 (es) * | 1994-10-20 | 2012-02-02 | Institut Pasteur | Secuencias nucleotídicas de antígenos retrovíricos vih-1 del grupo (o subgrupo) o. |
FR2731225B1 (fr) * | 1995-03-03 | 2003-10-31 | Pasteur Institut | Peptides de glycoproteine transmembranaire d'enveloppe et de proteine de capside du retrovirus humain du type hiv-1 et peptides presentant avec eux une parente immunologique |
US7090848B1 (en) * | 1998-08-04 | 2006-08-15 | Henry M. Jackson Foundation For The Advancement Of Military Medicine | HIV-1 envelope protein associated with a broadly reactive neutralizing antibody response |
US6911527B1 (en) | 1999-01-11 | 2005-06-28 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | HIV related peptides |
WO2000042068A2 (en) * | 1999-01-11 | 2000-07-20 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Hiv related peptides |
US8022040B2 (en) * | 2004-11-29 | 2011-09-20 | The Regents Of The University Of California | Hydroxyapatite-binding peptides for bone growth and inhibition |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4695624A (en) * | 1984-05-10 | 1987-09-22 | Merck & Co., Inc. | Covalently-modified polyanionic bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins with bigeneric spacers, and methods of preparing such polysaccharides and conjugates and of confirming covalency |
NZ214503A (en) * | 1984-12-20 | 1990-02-26 | Merck & Co Inc | Covalently-modified neutral bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins, and methods of preparing such polysaccharides and conjugates |
CA1339363C (en) * | 1987-05-01 | 1997-08-26 | Alan Ray Flesher | Monoclonal antibodies to specific antigenic regions of the human immunodeficiency virus and methods for use |
NL8702403A (nl) * | 1987-10-09 | 1989-05-01 | Stichting Centr Diergeneeskund | Oligopeptiden en gebruik daarvan voor diagnostische en vaccinatiedoeleinden voor aids en arc. |
EP0339504A3 (en) * | 1988-04-26 | 1990-09-12 | The Du Pont Merck Pharmaceutical Company | Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals |
AU640619B2 (en) * | 1988-10-03 | 1993-09-02 | Repligen Corporation | Hiv proteins and peptides useful in the diagnosis, prophylaxis or therapy of aids |
IL94558A0 (en) * | 1989-06-06 | 1991-03-10 | Merck & Co Inc | Conjugate immunogen for aids and vaccine and pharmaceutical compositions containing it |
-
1991
- 1991-08-05 IL IL99077A patent/IL99077A0/xx unknown
- 1991-08-06 NZ NZ239281A patent/NZ239281A/xx unknown
- 1991-08-07 EP EP19910202025 patent/EP0471407A3/en not_active Withdrawn
- 1991-08-07 CA CA002048594A patent/CA2048594A1/en not_active Abandoned
- 1991-08-09 PT PT98633A patent/PT98633A/pt not_active Application Discontinuation
- 1991-08-12 IE IE284691A patent/IE912846A1/en unknown
- 1991-08-12 KR KR1019910013847A patent/KR920004422A/ko not_active Application Discontinuation
- 1991-08-12 AU AU81777/91A patent/AU642751B2/en not_active Ceased
- 1991-08-12 NO NO91913127A patent/NO913127L/no unknown
- 1991-08-12 FI FI913817A patent/FI913817A/fi not_active Application Discontinuation
- 1991-08-13 JP JP3202789A patent/JPH06321808A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
EP0471407A3 (en) | 1993-05-12 |
PT98633A (pt) | 1992-06-30 |
IE912846A1 (en) | 1992-02-26 |
KR920004422A (ko) | 1992-03-27 |
CA2048594A1 (en) | 1992-02-14 |
NO913127D0 (no) | 1991-08-12 |
AU8177791A (en) | 1992-02-20 |
JPH06321808A (ja) | 1994-11-22 |
FI913817A0 (fi) | 1991-08-12 |
FI913817A (fi) | 1992-02-14 |
AU642751B2 (en) | 1993-10-28 |
EP0471407A2 (en) | 1992-02-19 |
NZ239281A (en) | 1993-09-27 |
NO913127L (no) | 1992-02-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0490806A3 (en) | Nasal pharmaceutical compositions | |
NZ222980A (en) | 3-aryloxy-3-substituted propanamines and pharmaceutical compositions | |
NZ223096A (en) | Peptidylaminodiols and pharmaceutical compositions | |
NZ222977A (en) | Aminotetralins and pharmaceutical compositions; 8-substituted-2-aminotetralins and pharmaceutical compositions thereof | |
IL106109A0 (en) | Vaccine compositions and their manufacture | |
IL106353A0 (en) | Unsymmetrical mono-3-nitro-bis-naphthalimides,their preparation and pharmaceutical compositions containing them | |
IL95351A0 (en) | 17beta-acyl-4-aza-5alpha-androst-1-en-3-ones and pharmaceutical compositions containing them | |
IL98499A0 (en) | Aminobenzodiazepines,their preparation and pharmaceutical compositions containing them | |
IL104999A0 (en) | Substituted phenylacetamides,their preparation and pharmaceutical compositions containing them | |
IL97122A0 (en) | Aromatase-inhibiting androstendiones and pharmaceutical compositions containing them | |
IL99077A0 (en) | New embodiments of the hiv principal neutralizing determinant and pharmaceutical compositions containing them | |
NZ233011A (en) | Thieno-triazole-diazepine and pharmaceutical compositions | |
NZ226450A (en) | Crystalline-1-carbacephalosporin and pharmaceutical compositions | |
IL105000A0 (en) | Imidazolyl-substituted phenylacetamides,their preparation and pharmaceutical compositions containing them | |
ZA903305B (en) | Thieno-triazolo-diazepine derivatives,a preparation process of the same and therapeutic compositions containing them | |
IL98934A0 (en) | Stable pharmaceutical compositions and their preparation | |
ZA902566B (en) | 2-substituted n,n'-ditrimethoxybenzoyl piperazines,a preparation process of the samde and therapeutic compositions containing them | |
IL99233A0 (en) | Phosphonopyrrolidine-and phosphonopiperidine-containing pseudopeptides of the statin type,their preparation and pharmaceutical compositions containing them | |
ZA911065B (en) | Chemical and pharmaceutical compositions | |
NZ219719A (en) | Endo-4-amino-5-chloro-2-methoxy-n-cl-azabicyclo -(3,3,1)-non-4-yl)-benzamide and pharmaceutical compositions | |
IL82726A (en) | Pharmaceutical compositions comprising anticonvulsively active 1-phenalkylimidazole-4-and/or-5-carboxamides and certain novel phenalkylimidazoles and their manufacture | |
NZ219748A (en) | Indenopyrimidines and pharmaceutical compositions | |
IL99011A0 (en) | 2-(9-fluorenonyl)-carbapenems and pharmaceutical compositions containing them | |
IL98911A0 (en) | 2-(9-fluorenonyl)-carbapenems and pharmaceutical compositions containing them | |
NZ218890A (en) | Fluorinated diaminoalkyne derivatives and pharmaceutical compositions |